Discovery of Selective P2Y6R Antagonists with High Affinity and In Vivo Efficacy for Inflammatory Disease Therapy.
Zhu Y, Zhou M, Cheng X, Wang H, Li Y, Guo Y, Wang Y, Tian S, Mao T, Zhang Z, Li D, Hu Q, Li H.
Zhu Y, et al. Among authors: li d, li y, li h.
J Med Chem. 2023 May 11;66(9):6315-6332. doi: 10.1021/acs.jmedchem.3c00210. Epub 2023 Apr 20.
J Med Chem. 2023.
PMID: 37078976